|
INSTRUCTIONS FOR AUTHORS
Revista Brasileira de Terapia Intensiva (Rev Bras Ter Intensiva, RBTI)
ISSN 0103-507X, is the Associação de Medicina Intensiva
Brasileira (AMIB)'s quarterly issued scientific journal, aimed to publish
relevant research involving acutely ill patients health care improvement,
providing evidence-based information discussion, distribution and promotion
to intensive care professionals. It publishes research, review, comments
and case report articles and letters to the Editor in all areas related
to severely ill patient's care.
The manuscripts can be either submitted in English, Portuguese or Spanish.
RBTI is published in a Portuguese printed version, and a Portuguese and
English electronic version. The journal will translate the articles submitted
in Portuguese
(or Spanish) and the translation costs will be covered by the journal.
Articles submitted in English will be translated by the journal into Portuguese,
with no expenses to the authors.
The submitted manuscripts will be initially checked by the Editor regarding
the minimal journal requirements and fulfillment of all manuscript submission
rules. Manuscripts without merit, bearing significant methodology errors,
or not fitting the journal's editorial policy will be rejected, with no
room for appeal. After the Editor's approval, the articles will be forwarded
for analysis by two or more reviewers. These will always be from institutions
that are different from the one the manuscript is from, being the anonymous
condition kept during the entire editorial process. The opinions expressed
in the articles, including reviewer-requested changes, will be the only
authors' responsibility. The time for the analysis is 30 days. After receiving
the reviewers' opinion, the authors will be allowed 60 days to submit
a new version including the suggested changes. If not submitted within
6 months, the manuscript will be removed from the data bank and an eventual
resubmission will follow the initial submissions track.
All submitted manuscripts should be accompanied by a letter signed by
all authors authorizing its publication, transferring copyright to the
journal, as well as declaring its originality, and that it was/is not
submitted for publication in any other journal.
This letter should have attached:
- Conflict of Interest Declaration, when appropriate. According
to the Federal Medical Council Decision #1595/2000 the Conflict of
Interest Declaration prohibits that any commercial products or equipments
are promoted or advertised in the article.
- Certificate of Approval by the Ethics Committee of the Institution
where the study was developed, or from another constituted EC.
- Information on eventual funding/financial support sources.
- For manuscripts including clinical information or pictures related
to individual patients, a signed (by the patient or a family member)
Informed Consent Form should be submitted for each patient.
Any either clinical or experimental, human or animal studies should have
been conducted in compliance with the Declaration of Helsinki, and this
should be mentioned on the section Methods.
Authorship criteria
Should be considered authors only those directly contributing to the article's
intellectual contents, according to the criteria below:
1. Created the initial idea and planned the study or interpreted the final
results OR
2. Wrote the manuscript or revised its successive versions AND
3. Approved the final version.
Administrative positions and data collection are not considered criteria
for authorship and, when appropriate, should be included in the Acknowledgements
session.
MANUSCRIPT
All articles should include:
Title page:
- Full title of the article
- All authors full names
- Each author institutional affiliation (only the main affiliation,
i.e. affiliation to the institution where the work was developed).
- Author for correspondence's complete address (including phone and
fax numbers and email).
- The Institution to be considered as responsible for sending the article.
- The project's funding source.
- Running title - An alternative title for the article, containing
up to 60 characters with spaces. This title should be displayed in all
article's sheet headings.
- Cover title - When the article's title has more than 100 characters
with spaces, an alternative title should be provided, including up to
100 characters (with spaces) to be displayed in the journal's cover.
Abstracts
Portuguese abstract: The Portuguese abstract should have up to 250 words,
and avoid abbreviations as far as possible. It should be structured with
the same chapters as the main text (Objective, Methods, Results and Conclusion),
and accurately reflect the main text contents. When the articles are Reports
or Case Report, the abstract doesn't need to be structured.
Summary Comments should be shorter than 100 words.
English Abstract: The English abstract has only to be provided for manuscripts
in this language. Manuscripts submitted in Portuguese will have their
Abstract translated into English.
Keywords
Six Portuguese and English terms should be provided defining the paper's
subject. These should be based on the DeSC (Health Sciences Descriptors),
a translation of the National Library of Medicine's MeSH (Medical Subject
Headings), available at http://decs.bvs.br.
Text
The articles should be submitted in MS Word® file with Times New
Roman 12 font, double space, including for tables, legends and references.
In all article categories the references should be numerical, superscripted,
and sequential.
Original articles
Are articles presenting investigational results. The text should have
up to 5000 words, excluding the title sheet, abstract, tables and references.
Articles larger than this should be approved by the Editor. The maximal
recommended number of authors is eight. If more authors have to be included,
this should be justified, explaining each author's participation. Original
articles should have:
Introduction - This section should be written from a non
area expert stand point, and clearly provide - and if possible, illustrate
- the rational for the research and its objectives. Clinical trial reports
should, whenever appropriate, include a literature research abstract,
indicating why the study was needed and the aimed study contribution.
This section should end with a short statement on the article reported
subject.
Methods - This should include the study design, the scenario,
type of participants or materials, clear interventions and comparisons
description, type of analysis used and their statistical power, if appropriate.
Results - The results should be presented in clear and logical sequence.
The statistical analysis results should include, when appropriate, the
relative and absolute risks or risk reductions, and confidence intervals.
Discussion - All results should be discussed and
compared to the relevant literature.
Conclusion - Should clearly discuss the main research conclusions
and provide clear explanation on its relevance.
References - Should be sequential according to the order
of quotation on text, and limited to 30 references. See below the reference
rules.
Review articles
A review article is a comprehensive description of certain health care
aspects relevant to the journal scope. Should have no more than 4000 words
(except the title sheet, abstract, tables and references) and up to 50
references. Should be written by acknowledgeable experienced authors,
and the authors number should not exceed three, except justification to
be submitted to the journal. The reviews may include: scientific reviews
- describing clinical impact sciences; "bedside bench" reviews
- describing the science supporting clinical situations; clinical reviews
- describing purely clinical situations. In reviews it is also recommended
having a "Methods" section, reporting the evidence sources and
the key words used for the literature search. Systematic literature reviews
containing appropriate search strategies and results are considered original
articles.
Pro/Cons clinical debates
Two invited authors discuss their different opinions on a specific clinical
subject. The subjects are identified in clinical scenarios written by
the section editor. Each author is requested to write a 800-1000 words
referenced article, describing if/why they agree or disagree with the
clinical scenario (Pro or Con). The con articles are show to the authors
for a shorter than 150 words response. The authors know who their opponent
is, but can't see the opposed article before submitting their own. The
500 words article should have no more than 15 references, and the 150
words response, 5 references. Randomized controlled studies published
in the last 10 years are preferable.
Comments
Are expert-written opinion articles, to be read by the general medical
community. Many are solicited, however unsolicited articles are also welcome,
and routinely revised. The comment objective should be highlighting an
issue, expanding the highlighted subject, and suggesting the sequence.
Any statement should be referenced, however it is preferable that the
reference list is limited to 15. For readability, the sentences should
be short and objective. Use subtitles for dividing the comments section.
This should be short, up to 800 to 1000 words, except the abstract and
references. The number of authors should not exceed two, unless justified.
Research comments
Research articles are frequently accompanied with comments. They aim to
describe the research qualities and/or faults, and its widened implications.
The research article discussed should be the first reference.
Recent publications comments
Last 6 months published research articles are elected by the editorial
board, reporting them as a comment.
Letters to the Editor
Comments to any article published in the journal, being an author's or
editor's response pertinent. Rebutter is not allowed. These should have
up to 400 words, up to 5 references, being the subject RBTI's article
the first mention in the text and references. The authors should also
submit their complete identification and address (including phone number
and email). All letters are edited and sent back to the authors before
publication.
Acknowledgements
The authors should use this section to thank eventual research funding
and academic organisms' support; foment agencies; colleagues and other
collaborators. The authors should grant permission from all mentioned
in the acknowledgments section. This should be concise, not exceeding
4 lines.
References
Should be updated, preferably containing the most relevant articles published
on the subject in the last five years. Should not contain articles not
quoted in text or unpublished works. The references should be consecutively
numbered in the text quotation sequence, and identified with Arabic numerals.
The display should comply with the Vancouver Style format, as in the models
below. The journal titles should be abbreviated according to the National
Library of Medicine, available at the List of Journal Indexed in Index
Medicus, at http://www.ncbi.nlm.nih.gov/entrez/
query.fcgi?db=journals.
For all references, mention up to six authors. In case of more than six
authors, mention the first six authors followed by the expression et al.
Printed Articles
Dellinger RP, Vincent JL, Silva E, Townsend S, Bion J, Levy MM. Surviving
sepsis in developing countries. Crit Care Med. 2008;36(8):2487-8.
Levy MM, Vincent JL, Jaeschke R, Parker MM, Rivers E, Beale R, et al.
Surviving Sepsis Campaign: Guideline Clarification. Crit Care Med. 2008;36(8):2490-1.
Electronic Articles
Buerke M, Prondzinsky R. Levosimendan in cardiogenic shock: better than
enoximone! Crit Care Med [Internet]. 2008 [cited 2008 Aug 23];36(8):2450-1.
Available from: http://www.ccmjournal.com/pt/re/ccm/abstract.00003246-200808000-00038.htm
;jsessionid=LWTRDHyTFs6cTtCHrnxTjpHBBvkgdDG7qVyn12SGJw1dn99ynQ4W!1177656273!181195629!8091!-1
Hecksher CA, Lacerda HR, Maciel MA. Características e evolução
dos pacientes tratados com drotrecogina alfa e outras intervenções
da campanha "Sobrevivendo à Sepse" na prática
clínica. Rev Bras Ter Intensiva [Internet]. 2008[citado 2008 Ago
23; 20(2): 135-43. Available at: <http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-507X2008000200004&lng=pt&nrm=iso>.
ISSN 0103-507X
Supplements
Walker LK. Use of extracorporeal membrane oxygenation for preoperative
stabilization of congenital diaphragmatic hernia. Crit Care Med. 1993;21
(Supp. l):S379-S380.
Books
Doyle AC. Biological mysteries solved. 2nd ed. London: Science Press;
1991.
Book chapters
Lachmann B, van Daal GJ. Adult respiratory distress syndrome: animal models.
In: Robertson B, van Golde LM. Pulmonary surfactant. 2nd ed. Amsterdam:
Elsevier; 1992. p. 635-66.
Published abstracts
Varvinski AM, Findlay GP. Immediate complications of central venous cannulation
in ICU [ abstract]. Crit Care. 2000;4(Suppl 1):P6.
In press articles
Beigel JH. Influenza.Crit Care Med. In press 2008.
Tables and figures
All figures and tables should be numbered according to the text mention
order. Tables and figures should be inserted below the text, following
references, only one each page, the later preferably prepared as MS Excel®,
TIF, or JPG with 300 DPI files. Figures needing increased resolution should
be submitted in files apart. Figures containing texts should be provided
in open files, for translation. If not possible, the author should provide
the translation.
The quantities, units and symbols used should adhere to national rules.
The tables and figures legends should be concise but self-explaining,
allowing understanding without consulting the text. The units should be
in the table's body, and statistical tests indicated below the table.
The figures should have legends explaining the results, allowing understanding
without consulting the text. Surgery and biopsy pictures with special
staining techniques will be considered for color printing, being the additional
costs the authors' responsibility. Already published figures should be
accompanied with the author/editor authorization.
Reproduced figures, charts, plots or tables, not originally belonging
to the article, should reference the original source.
Abbreviations and initials
The use of abbreviations should be avoided in the article's title, abstract
and tables and figures headings. Their use should be minimized in the
entire text. They should be preceded by the entire name when first mentioned
in the text. The abbreviations, symbols and other signs meanings should
be provided in the figures and tables foot notes.
|
|
All the content of the journal, except where otherwise noted, is licensed under
a Creative
Commons License